Reimbursement & Directory Validation Update

Reimbursement Change
Effective Oct. 1, BCBSWY will begin using J-code level pricing for J-1745 (infliximab). We will no longer be pricing this medication at the NDC code level. Reimbursement will be at the biosimilar rate.

Directory Validation Tip
In Availity, beneath the user account, please select “Manage My Organization” to make updates. (See screenshot below.) Additional instructions are located here to help you find NPI and tax ID combinations. This helps facilitate compliance with the No Surprises Act (NSA) provider directory validation requirements. The NSA requires you confirm this information with us every 90 days, so your information can continue to be listed in our public directory.

Share

Related Posts
Annual Survey Coming Soon
Survey Coming Soon  BCBSWY asks for your feedback to help us improve our programs and services. We invite you to participate in our annual…
Reimbursement & Directory Validation Update
Reimbursement Change Effective Oct. 1, BCBSWY will begin using J-code level pricing for J-1745 (infliximab). We will no longer be pricing this medication at…
Holiday Closure & Authorization Pre-Check Tip 
Holiday Closure Our offices will be closed in observance of Labor Day on Monday, Sept. 5. Authorization Pre-Check Tip Providers can use the Authorization…

Fewer Hassles. Better Service.

Back to Top